Efficacy of palonosetron for the prevention of postoperative nausea and vomiting: a randomized, double-blinded, placebo-controlled trial

The aim of this study was to evaluate the efficacy of palonosetron, the latest 5-HT3 receptor antagonist, for the prevention of postoperative nausea and vomiting (PONV) during the first 72 h after operation. In this randomized, double-blinded, placebo-controlled study, 204 healthy inpatients who wer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of anaesthesia : BJA 2014-03, Vol.112 (3), p.485-490
Hauptverfasser:	Chun, H.R., Jeon, I.S., Park, S.Y., Lee, S.J., Kang, S.H., Kim, S.I.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged anti-emetics Antiemetics - adverse effects Antiemetics - therapeutic use Double-Blind Method Female Follow-Up Studies Humans Isoquinolines - adverse effects Isoquinolines - therapeutic use Male Middle Aged palonosetron postoperative nausea and vomiting Postoperative Nausea and Vomiting - diagnosis Postoperative Nausea and Vomiting - epidemiology Postoperative Nausea and Vomiting - prevention & control Quinuclidines - adverse effects Quinuclidines - therapeutic use Risk Assessment Sample Size Surgical Procedures, Operative Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!